Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, FY2025
-13,741
Period ended Dec 31, 2025
Change on a year earlier
+77.7%
-7,734 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Cash Used in Investing Activities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -13,741 | +77.7% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | -7,734 | -45.1% | Form 10-K (filed 2025-02-25) ↗ |
| FY2023 | Dec 31, 2023 | -14,083 | +183.9% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | -4,960 | -69.8% | Form 10-K (filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | -16,421 | +78.6% | Form 10-K (filed 2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | -9,193 | +263.5% | Form 10-K (filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | -2,529 | -158.6% | Form 10-K (filed 2022-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 4,314 | +61.0% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 2,679 | -183.5% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | -3,210 | -32.5% | SEC Filing ↗ |
| FY2015 | Dec 31, 2015 | -4,758 | +1,172.2% | Form 10-K (filed 2016-02-26) ↗ |
| FY2014 | Dec 31, 2014 | -374 | -88.1% | Form 10-K (filed 2015-02-27) ↗ |
| FY2013 | Dec 31, 2013 | -3,148 | -53.7% | Form 10-K (filed 2014-02-27) ↗ |
| FY2012 | Dec 31, 2012 | -6,805 | +135.5% | Form 10-K (filed 2013-02-28) ↗ |
| FY2011 | Dec 31, 2011 | -2,890 | -17.4% | Form 10-K (filed 2012-02-28) ↗ |
| FY2010 | Dec 31, 2010 | -3,497 | -210.8% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 3,156 | -272.1% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | -1,834 | -34.7% | Form 10-K (filed 2011-02-28) ↗ |
| FY2007 | Dec 31, 2007 | -2,810 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Merck Net Cash Used in Investing Activities ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_cf_icf
See every metric in the Merck KPI table. Data updated Oct 26, 2026.